Expected returns an investor s guide to harvesting market rewards 1st edition ilmanen antti complete

Page 1


Visit to download the full and correct content document: https://textbookfull.com/product/expected-returns-an-investor-s-guide-to-harvesting-m arket-rewards-1st-edition-ilmanen-antti/

More products digital (pdf, epub, mobi) instant download maybe you interests ...

Stocks for the long run the definitive guide to financial market returns long term investment strategies Siegel

https://textbookfull.com/product/stocks-for-the-long-run-thedefinitive-guide-to-financial-market-returns-long-terminvestment-strategies-siegel/

Recipe for Success An Insider s Guide to Bringing Your Natural Food to Market Abig Steinberg

https://textbookfull.com/product/recipe-for-success-an-insider-sguide-to-bringing-your-natural-food-to-market-abig-steinberg/

The Global Market for Investor Citizenship Jelena Džanki■

https://textbookfull.com/product/the-global-market-for-investorcitizenship-jelena-dzankic/

Stocks for the Long Run The Definitive Guide to Financial Market Returns Long Term Investment Strategies 5th Edition Jeremy J. Siegel

https://textbookfull.com/product/stocks-for-the-long-run-thedefinitive-guide-to-financial-market-returns-long-terminvestment-strategies-5th-edition-jeremy-j-siegel/

Investing in India Website A Value Investor s Guide to the Biggest Untapped Opportunity in the World 1st Edition

https://textbookfull.com/product/investing-in-india-website-avalue-investor-s-guide-to-the-biggest-untapped-opportunity-inthe-world-1st-edition-rahul-saraogi/

The Economist guide to investment strategy how to understand markets risk rewards and behaviour Peter Stanyer

https://textbookfull.com/product/the-economist-guide-toinvestment-strategy-how-to-understand-markets-risk-rewards-andbehaviour-peter-stanyer/

Technical Analysis Explained The Successful Investor s Guide to Spotting Investment Trends and Turning Points 5th Edition Martin J. Pring

https://textbookfull.com/product/technical-analysis-explainedthe-successful-investor-s-guide-to-spotting-investment-trendsand-turning-points-5th-edition-martin-j-pring/

Foundations of Consciousness 1st Edition Antti Revonsuo

https://textbookfull.com/product/foundations-ofconsciousness-1st-edition-antti-revonsuo/

Essential Rainwater Harvesting A Guide to Home Scale System Design Rob Avis

https://textbookfull.com/product/essential-rainwater-harvestinga-guide-to-home-scale-system-design-rob-avis/

Table of Contents

Title Page

Copyright Page

Foreword

Dedication

Acknowledgments

Abbreviations and acronyms

Disclaimer

Part I - Overview, historical returns, and academic theories

Chapter 1 - Introduction

1.1 HISTORICAL PERFORMANCE

1.2 FINANCIAL AND BEHAVIORAL THEORIES: A BRIEF HISTORY OF IDEAS

1.3 FORWARD-LOOKING INDICATORS

1.4 VIEW-BASED EXPECTED RETURNS

1.5 GENERAL COMMENTS ABOUT THE BOOK

1.6 NOTES

Chapter 2 - Whetting the appetite: Historical averages and forward-looking returns

2.1 HISTORICAL PERFORMANCE SINCE 1990

2.2 SAMPLE-SPECIFIC RESULTS: DEALING WITH THE PITFALLS

2.3 FORWARD-LOOKING RETURN INDICATORS

2.4 NOTES

Chapter 3 - The historical record: The past 20 years in a longer perspective

3.1 STOCKS

3.2 BONDS

3.3 REAL ASSET INVESTING AND ACTIVE INVESTING

3.4 FX AND MONEY MARKETS

3.5 REAL RETURN HISTORIES

3.6 NOTES

Chapter 4 - Road map to terminology

4.1 CONSTANT OR TIME-VARYING EXPECTED RETURNS?

4.2 RATIONAL OR IRRATIONAL EXPECTATIONS FORMATION?

4.3 RETURN MEASUREMENT ISSUES

4.4. RETURNS IN WHAT CURRENCY?

4.5 RISK-ADJUSTED RETURNS

4.6 BIASED RETURNS

4.7 NOTES

Chapter 5 - Rational theories on expected return determination

5.1 THE OLD WORLD

5.2 THE NEW WORLD

5.3 DETOUR: A BRIEF SURVEY OF THE EFFICIENT MARKETS HYPOTHESIS

5.4 NOTES

Chapter 6 - Behavioral finance

6.1 LIMITS TO ARBITRAGE

6.2 PSYCHOLOGY

6.3 APPLICATIONS

6.4 CONCLUSION

6.5 NOTES

Chapter 7 - Alternative interpretations for return predictability

7.1 RISK PREMIA OR MARKET INEFFICIENCY

7.2 DATA MINING AND OTHER “MIRAGE” EXPLANATIONS

7.3 NOTES

Chapter 8 - Equity risk premium

8.1 INTRODUCTION AND TERMINOLOGY

8.2 THEORIES AND THE EQUITY PREMIUM PUZZLE

8.3 HISTORICAL EQUITY PREMIUM

8.4 FORWARD-LOOKING (EX ANTE OBJECTIVE) LONG-TERM EXPECTED RETURN MEASURES

8.5 SURVEY-BASED SUBJECTIVE EXPECTATIONS

8.6 TACTICAL FORECASTING FOR MARKET TIMING

8.7 NOTES

Chapter 9 - Bond risk premium

9.1 INTRODUCTION, TERMINOLOGY, AND THEORIES

9.2 HISTORICAL AVERAGE RETURNS

9.3 ALTERNATIVE EX ANTE MEASURES OF THE BRP

9.4 YIELD CURVE STEEPNESS: IMPORTANT PREDICTIVE RELATIONS

9.5 EXPLAINING BRP BEHAVIOR: FIRST TARGETS, THEN FOUR DRIVERS

9.6 TACTICAL FORECASTING—DURATION TIMING

9.7 NOTES

Chapter 10 - Credit risk premium

10.1 INTRODUCTION, TERMINOLOGY, AND THEORY

10.2 HISTORICAL AVERAGE EXCESS RETURNS

10.3 FOCUS ON FRONT-END TRADING—A POCKET OF ATTRACTIVE REWARD TO RISK

10.4 UNDERSTANDING CREDIT SPREADS AND THEIR DRIVERS

10.5 TACTICAL FORECASTING OF CORPORATE BOND OUTPERFORMANCE

10.6 ASSESSING OTHER NON-GOVERNMENT DEBT

10.7 CONCLUDING REMARKS

10.8 NOTES

Chapter 11 - Alternative asset premia

11.1 INTRODUCTION TO ALTERNATIVES

11.2 REAL ESTATE

11.3 COMMODITIES

11.4 HEDGE FUNDS

11.5 PRIVATE EQUITY FUNDS

11.6 NOTES

Chapter 12 - Value-oriented equity selection

12.1 INTRODUCTION TO DYNAMIC STRATEGIES

12.2 EQUITY VALUE: INTRODUCTION AND HISTORICAL PERFORMANCE

12.3 TWEAKS INCLUDING STYLE TIMING

12.4 THE REASONS VALUE WORKS

12.5 DOES THE VALUE STRATEGY WORK IN EQUITIES BEYOND INDIVIDUAL STOCK SELECTION ...

12.6 RELATIONS BETWEEN VALUE AND OTHER INDICATORS FOR EQUITY SELECTION

12.7 NOTES

Chapter 13 - Currency carry

13.1 INTRODUCTION

13.2 HISTORICAL AVERAGE RETURNS

13.3 IMPROVEMENTS/REFINEMENTS TO THE BASELINE CARRY STRATEGY

13.4 WHY DO CARRY STRATEGIES WORK?

13.5 CARRY HERE, CARRY THERE, CARRY EVERYWHERE

13.6 NOTES

Chapter 14 - Commodity momentum and trend following

14.1 INTRODUCTION

14.2 PERFORMANCE OF SIMPLE COMMODITY MOMENTUM STRATEGIES

14.3 TWEAKS

14.4 WHY DOES MOMENTUM—SUCH A NAIVE STRATEGY—WORK?

14.5 MOMENTUM IN OTHER ASSET CLASSES

14.6 NOTES

Chapter 15 - Volatility selling (on equity indices)

15.1 INTRODUCTION

15.2 HISTORICAL PERFORMANCE OF VOLATILITY-TRADING STRATEGIES

15.3 TWEAKS/REFINEMENTS

15.4 THE REASONS VOLATILITY SELLING IS PROFITABLE

15.5 OTHER ASSETS

15.6 NOTES

Chapter 16 - Growth factor and growth premium

16.1 INTRODUCTION TO UNDERLYING FACTORS IN CHAPTERS 16–19

16.2 INTRODUCTION TO THE GROWTH FACTOR

16.3 THEORY AND EVIDENCE ON GROWTH

16.4 ASSET MARKET RELATIONS

16.5 TIME-VARYING GROWTH PREMIUM

16.6 NOTES

Chapter 17 - Inflation factor and inflation premium

17.1 INTRODUCTION

17.2 INFLATION PROCESS—HISTORY, DETERMINANTS, EXPECTATIONS

17.3 INFLATION SENSITIVITY OF MAJOR ASSET CLASSES AND THE INFLATION PREMIUM

17.4 TIME-VARYING INFLATION PREMIUM

17.5 NOTES

Chapter 18 - Liquidity factor and illiquidity premium

18.1 INTRODUCTION

18.2 FACTOR HISTORY: HOW DOES LIQUIDITY ITSELF VARY OVER TIME?

18.3 HISTORICAL EVIDENCE ON AVERAGE LIQUIDITY-RELATED PREMIA

18.4 TIME-VARYING ILLIQUIDITY PREMIA

18.5 NOTE

Chapter 19 - Tail risks (volatility, correlation, skewness)

19.1 INTRODUCTION

19.2 FACTOR HISTORY

19.3 HISTORICAL EVIDENCE ON AVERAGE ASSET RETURNS VS. VOLATILITY AND CORRELATION

19.4 THEORY AND EVIDENCE ON THE SKEWNESS PREMIUM

19.5 VERDICT ON WHY HIGH-VOLATILITY ASSETS FARE SO POORLY

19.6 TIME-VARYING PREMIA FOR TAIL RISK EXPOSURES

19.7 NOTES

Part III - Back to broader themes

Chapter 20 - Endogenous return and risk: Feedback effects on expected returns

20.1 FEEDBACK LOOPS ON THE DIRECTION OF RISKY ASSETS

20.2 FEEDBACK LOOPS ON LESS DIRECTIONAL POSITIONS

20.3 AGENDA FOR MARKET-TIMERS AND RESEARCHERS

20.4 NOTES

Chapter 21 - Forward-looking measures of asset returns

21.1 POPULAR VALUE AND CARRY INDICATORS AND THEIR PITFALLS

21.2 BUILDING BLOCKS OF EXPECTED RETURNS

21.3 NOTES

Chapter 22 - Interpreting carry or non-zero yield spreads

22.1 INTRODUCTION

22.2 FUTURE EXCESS RETURNS OR MARKET EXPECTATIONS?

22.3 EMPIRICAL HORSE RACES FOR VARIOUS ASSETS

22.4 CONCLUSIONS

22.5 NOTES

Chapter 23 - Survey-based subjective expected returns

23.1 NOTES

Chapter 24 - Tactical return forecasting models

24.1 INTRODUCTION

24.2 WHAT TYPE OF MODEL?

24.3 WHICH ASSETS/TRADES?

24.4 WHICH INDICATOR TYPES?

24.5 ENHANCEMENTS AND PITFALLS

24.6 NOTES

Chapter 25 - Seasonal regularities

25.1 SEASONAL, CYCLICAL, AND SECULAR PATTERNS IN ASSET RETURNS

25.2 MONTHLY SEASONALS AND THE JANUARY EFFECT

25.3 OTHER SEASONALS

Chapter 26 - Cyclical variation in asset returns

26.1 TYPICAL BEHAVIOR OF REALIZED RETURNS AND EX ANTE INDICATORS THROUGH THE ...

26.2 TYPICAL BEHAVIOR OF REALIZED RETURNS AND EX ANTE INDICATORS ACROSS ...

26.3 NOTES

Chapter 27 - Secular trends and the next 20 years

27.1 CONTRASTING 1988–2007 WITH 1968–1987

27.2 REVERSIBLE AND SUSTAINABLE SECULAR TRENDS

27.3 THE NEXT 20 YEARS

27.4 NOTES

Chapter 28 - Enhancing returns through managing risks, horizon, skill, and costs

28.1 INTRODUCTION: HOW CAN INVESTORS ENHANCE RETURNS?

28.2 RISK

28.3 INVESTMENT HORIZON

28.4 SKILL

28.5 COSTS

28.6 NOTES

Chapter 29 - Takeaways for long-horizon investors

29.1 KEY TAKEAWAYS FROM THEORY

29.2 EMPIRICAL RETURN SOURCES

29.3 MY TAKE ON KEY DEBATES

29.4 KNOW THYSELF: LARGE LONG-HORIZON INVESTORS’ NATURAL EDGES

29.5 INSTITUTIONAL PRACTICES

29.6 NOTES

Appendix A - World wealth

Appendix B - Data sources and data-series construction

Bibliography

Index

For other titles in the Wiley Finance Series please see www.wiley.com/finance

This edition first published 2011 © 2011 Antti Ilmanen

Registered office

John Wiley & Sons Ltd, The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, United Kingdom

For details of our global editorial offices, for customer services and for information about how to apply for permission to reuse the copyright material in this book please see our website at www.wiley.com

The right of the author to be identified as the author of this work has been asserted in accordance with the Copyright, Designs and Patents Act 1988.

All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, except as permitted by the UK Copyright, Designs and Patents Act 1988, without the prior permission of the publisher.

Wiley also publishes its books in a variety of electronic formats. Some content that appears in print may not be available in electronic books.

Designations used by companies to distinguish their products are often claimed as trademarks. All brand names and product names used in this book are trade names, service marks, trademarks or registered trademarks of their respective owners. The publisher is not associated with any product or vendor mentioned in this book. This publication is designed to provide accurate and authoritative information in regard to the subject matter covered. It is sold on the understanding that the publisher is not engaged in rendering professional services. If professional advice or other expert assistance is required, the services of a competent professional should be sought.

ISBN 978-1-119-99072-7

A catalogue record for this book is available from the British Library.

Project management by OPS Ltd, Gt Yarmouth, Norfolk

Typeset in 10/12pt Times

Foreword

The first time I met Antti Ilmanen I thought he was insane. I was right. But, I was to discover quickly he was insane in a good way. The incident in question was at a new Ph.D. student mixer, about as exciting as it sounds, where seconds after being introduced to Antti he asked me “who do you rate in the top-five academics in finance and why?” He had his own answers on a set of Post-it notes. By the way, Antti has become famous for these Post-it notes. Suffice it to say if he consults the Post-its, and says you said something 17 years ago that turned out to be disproved in the latest Journal of Finance paper, just assume he’s right and move on.

Getting back to my story, he couldn’t understand how I couldn’t name five. Truth be told I probably could have named maybe three academics in total, and as to justifying my choices with “why?”, I was stuck at zero. I had not chosen finance because, like Antti, I was already obsessed with it. I chose it as my dad, a lawyer, forbade me to go to law school, I had some mild ability at mathematics, I recognized that finance might be both intellectually interesting and provide a good living, and finally I chose a Ph.D. as being a professor seemed like a nice life (little did I know the Sirens of Wall Street would soon call me away . . .) Antti looked at me with a “what the heck are you doing in the Ph.D. program” confused stare, and I politely ran away from the very intense, very finance-obsessed young Finn. Now, 20+ years later, and after countless similar incidents, I no longer run away (he finds me anyway), but he’s still intense and obsessed with finance. Over the years, and specifically through this book, those traits of his have made us all better off.

One more aside before my foreword begins in earnest. I briefly considered not writing this foreword in protest or as a rearguard action. Antti gives away a lot in this book. Perhaps few true secrets (though there are some!), as this is more a textbook than original research. But he makes much of what has become called “quantitative finance” easily (OK, 300+ dense pages, in original format, of “easily”) accessible in one place. Long term, that can’t be good for people like me who make their livings from this stuff being at least a bit secret. But being skilled at game theory I quickly determined that if I didn’t write the foreword somebody else would, so refusal would not accomplish much. With that strategy shot down, I very fleetingly considered having him killed, but this seemed to entail too much “tail risk” (see Chapters 15 and 19) and, anyway, is at least somewhat morally ambiguous. Besides, Antti’s just the type to have stashed a Post-it at his lawyer with a note “in the event of my untimely . . .” So in the end I decided to smile and write the foreword, and just resolve to work harder (along with many others at my firm and others throughout the field) to give Antti material for a sequel 20+ years from now!

Now let’s talk about the title subject.

Expected returns are how much you make on average over time on an investment or strategy. Risk is the possibility that, over any time horizon, you never get your expectation, as once again the world interferes with a perfectly good plan. Risk can make you fail to reach your expectations because of the simple uncertainty around expectations it brings, or because, as in 2008 for many, bad realizations call into question long-term survival or at least the ability to stick with a plan. Still, expected returns are incredibly important. If you survive and stick to a good plan, they add up nicely.

Antti has chosen to write a book on expected return in the Age of Risk. Risk, and particularly risk in the sense of survival, is all the rage in these days following a major financial crisis. This wide-ranging discussion of risk is right and proper. If some investors took too much risk and that caused or exacerbated the financial crisis, that’s a pretty important event to learn from. If some investors thought risk was simple and all figured out, and got a black swan dropped on their heads, it is important to learn from that too. However, it’s not the whole story.

While perhaps differing from the vast majority of risk-focused researchers and authors these days, I’d argue that the study of expected returns deserves more of our attention, even just after one of the biggest “left tails” in history. For one thing, as scary as the world got, some of our much maligned simple “normal” models actually did OK for all assets other than highly structured and/or levered ones, or over the very short term (see http://www.dimensional.com/famafrench/2009/05/how-unusual-wasthe-stock-market-of-2008.html). For another thing, in a theme Antti returns to again and again in his book, expected returns don’t have to stay the same throughout time. Part of what we see as “risk” materializing during events like the 2008 financial crisis, and the 1999–2000 tech bubble, are more accurately seen as investors misunderstanding or misestimating expected returns. In both those cases the extreme dénouement that followed occurred, at least according to many (and me), because before the disaster, investors were willing to accept far too low an expected return, first on stocks and specifically on technology stocks, and then a decade later on credit and real estate. In both the theory and the reality of these globe-shaking events, the discussions of risk and expected return are intimately linked.

So why so much more discussion of risk than expected return these days? Well, obviously the magnitude of recent events makes all of us greatly value the chance we could have avoided that pain. But again, a careful study of expected return might have easily, perhaps even more easily, led to the same protection by avoiding certain investments on the ground that their expected returns were too low. Frankly, I think a lot of the answer is that discussing risk is inherently sexier than discussing expected returns. Good forecasts of expected return add up over the long term, but don’t matter for squat next week. Risk can kill you, or make you a hero, in the time it takes you to say “flash crash”. Would you rather write about a tsunami or erosion? More specifically, from a safe perch, say the hindsight of authoring a book, which event would be more dramatic to narrate? The analogy, forced though it may be, continues to work as erosion, or expected return, might be mind-numbingly boring at any one moment, but it has a heck of a lot to say about how the future will be shaped.

For perspective, you want to see a black swan? Try making nothing on your equities in your final 20 years until retirement because you bought them at an extremely high price (low expected return). That is one pile of ebony long-necked bird. If risk is about surviving the short term, expected return is about whether, after surviving, you think it was worth it.

Here’s another secret. Besides being at least as important, estimating expected returns is much harder than estimating risk. Now, estimating risk is no easy task. But at least finance wears its insecurity on its sleeve here. Are returns “normal” or do we have to worry about “black swans”, “fat tails”, and all that? This worry and effort is worthwhile, but those trying to estimate the expected return on various assets smile at those taking on the comparatively easy task of estimating risk. Basically, you need a heck of a lot more data to estimate expected returns than to estimate risk. In geek-speak, the first moment laughs at and taunts the second moment (which I’m going to pretend for a second is all you need for risk). The second moment gives up its secrets reluctantly, but far more readily than that more covert first moment. To estimate risk we lament (as statisticians not humanitarians) that we don’t get to see a few more disasters. To estimate expected return we lament we don’t get to see a few more centuries.

Now that the motivation behind and the difficulty of Antti’s task is clear, let’s talk about how one might actually try to forecast expected returns. Starting with the very big picture, why is there a positive expected return (let’s make that positive relative to some riskless rate or, in other words, a positive risk premium) on any asset or investment strategy? Well, there are two possible reasons. First, in a rational world you should get paid a positive expected return for bearing a risk others don’t wish to bear. As an aside, Antti repeatedly hammers home the poorly understood point that you should get paid particularly well for bearing risks that hurt you exactly when it is most painful to be hurt, and less or not at all for risks that only bring you harm when all is well. Second, in a world that permits some irrationality, you can also get paid for someone else’s systematic mistakes (or pay for your own).

While this parsing is useful, and Antti makes great use of it throughout the book, he takes it further, examining expected returns along three different dimensions (and asking the rational vs. irrational question for each part):

1. The expected return you get paid for owning any of the major asset classes (stocks, bonds, commodities, etc.).

2. The expected return you get from pursuing well-known strategies such as value investing, momentum investing, and carry-based investing. These are fundamentally different from the returns in (1) as, for instance, in examining value investing you don’t count the expected return from just being long stocks, but rather the extra return that has historically accrued to value stocks vs. the universe of all stocks. These strategies also tend to be far more dynamic than the asset classes in (1), changing their portfolio holdings more often through time.

3. The expected return you get from being willing to take the risk of being exposed to economic or other risks (e.g., shocks to growth, shocks to inflation, liquidity risk, etc.).

These are all connected and overlapping. For instance, passive ownership of equities exposes you more to risk of poor real economic growth than does passive ownership of bonds, which exposes you more to risk of higher-than-expected inflation. Small stocks expose you to more liquidity risk than large ones. The overlapping descriptions go on and on. Antti doesn’t mean for these three ways to look at expected returns to be a clean decomposition, rather he finds use for all three at once (remember, he calls this art and science). He continually stresses that there is no perfect way to examine (or later forecast) expected returns. You want to use every framework that is useful and brings anything new to the study. In this sense his three-way examination succeeds handily.

OK, let’s recap. So there are two ways you can get a positive expected return, by taking a risk you get paid for (roughly, “beta”), or by outsmarting someone else (“alpha”). There are three useful perspectives to examine the source of expected returns: asset classes, systematic strategies, and risk factors such as economic growth and liquidity. Exposure to any of these three can generate a positive return for either of the first two reasons (rational compensation for risk, or outsmarting of others who are less than rational). Now we’re cooking. All we need now—assuming we have identified one or more of the three categories of sources of expected returns (from the overlapping categories of asset class, strategy, and risk factor exposure) and have a theory as to why an investor gets paid this expected return (rational vs. irrational)—is a way to estimate the size of that expected return going forward. Here, you guessed it, Antti gives us not one but three very useful methods. They are again complementary—not competitors. In order from weakest to strongest (Antti’s ordering which I agree with): (1) you can forecast the future from looking purely at how something has done in the past, (2) you can forecast the future based solely on your theory of how the world should work without examining data, (3) you can jump straight to current measures (e.g., the P/E of the stock market, the nominal or real yield on bonds) and use them to forecast. Like Antti, for reasons you’ll have to get from the book, I favor (3), but even using current measures like P/E and yield you still need history and theory. You would like some theory to guide why you think today’s stock market P/E should be related to its future return, and probably would like some evidence that this has historically been an effective tool.

So, remember, there are two reasons you might get paid an expected return, three overlapping ways to parse the different sources of expected returns, and three non-mutually exclusive methods to estimate the expected return going forward, all probably containing part but not all the truth, so all must be strongly considered, but none blindly, and all at once. You got that?

Well, I didn’t promise you this would be simple, did I? In fact, I told you the opposite. Expected returns are interesting precisely because they are hard (and very important)! This means there is no easy answer. But, it also means that effort on this front is potentially highly valuable. Understanding easy but very important problems is also important, but the barriers to entry are low, and getting an advantage from such an easy understanding is usually difficult because the understanding is so widespread. (On the other hand, the investing public’s continued failure to understand basic ideas like diversifying widely, keeping average costs low, and realizing that it is hard to beat the market, etc., makes even this effort worthwhile to the marginal investor.) But, understanding deeply, if imperfectly, what many don’t understand at all or even get backwards (like the common error of thinking expected returns are especially high going forward after realized returns have had an exceptionally good run), well, that is great stuff!

Antti’s book is complicated and dense. The best compliment I can pay it is that it’s not more complicated than it has to be. It chooses to take on a hard question and is honest about this degree of difficulty. It chooses to offer multiple overlapping methods at each point, as there truly is not one certain method, and each brings some value. Another, far weaker, even harmful, book could tell you that forecasting long-term future returns is easy. That all you have to do is listen to the author’s simple formula and prosper (Dow 36,000 anyone?). Antti tells you it’s hard. He says if you follow our best minds, and use the best data we have, you probably have an edge, or at least your mistakes are not silly, but he says it is art and science, and makes no guarantees.

If I can leave you with advice that applies directly to Antti’s book, but is actually far more general, it’s to listen to people who take on difficult problems boldly. Listen to people who are honest that our best hope is improved but not perfect understanding. Listen to people who aren’t afraid to tell you the world is a complicated place, but then are damned talented at making it as simple as possible (but no simpler).

In other words, read this book. Listen to Antti.

The information set forth herein has been obtained or derived from sources believed by the author to be reliable. However, the author does not make any representation or warranty, express or implied, as to the information’s accuracy or completeness, nor does the author recommend that the attached information serve as the basis of any investment decision. This document has been provided to you solely for information purposes and does not constitute an offer or solicitation of an offer, or any advice or recommendation, to purchase any securities or other financial instruments, and may not be construed as such. This document is intended exclusively for the use of the person to whom it has been delivered by the author, and it is not to be reproduced or redistributed to any other person.

Dedicated to Rory Byrne, in memoriam

Acknowledgments

I have been a student of expected asset returns for over 20 years while wearing many different hats: buy-side bond portfolio manager in the Finnish central bank, Ph.D. scholar at the University of Chicago (UofC), bond research analyst at Salomon Brothers, sell-side strategist and prop trader at Salomon/Citigroup, and hedge fund trader and strategist at Brevan Howard. I have also advised various institutional investors on their long-term investment strategies—most regularly for Norway’s sovereign wealth fund in semiannual expert panel meetings. It is mainly this last experience that has inspired this book.

OK, that was too mildly put. I confess: I have been obsessed with expected returns. The passion for the topic arose in as different places as the Bank of Finland in Helsinki and the UofC campus in Hyde Park.

I earned my finance doctorate at the University of Chicago Business School (now the Booth School of Business) in the early 1990s, with Professors Eugene Fama and Kenneth French as my dissertation chairmen. In many minds this background puts me squarely in the efficient markets’ camp. However, we Chicago finance students were not taught a dogma. Instead, we were given a lifelong desire to learn more about financial markets with the emphasis on an empirical approach: let ideas compete freely and let data be the judge. The EMH paradigm gave a very useful framework for understanding and analyzing markets, but few of us became EMH purists. Indeed, many of the anomalies that challenged the EMH were uncovered by Chicago professors and students. I hope that readers will find my treatment of risk-based and behavioral explanations for expected returns surprisingly balanced.

Fama and French are also among my leading lights when I tackle that perennial question “if your ideas have any investment value, why would you share them?” Evidence abounds that business gains accrue to perceived thought-leaders. Yet, many serious writers publish for less selfish reasons as well. They want to enhance the general investor experience and improve the marketplace.

Chicago also had other superb finance and economics professors and besides faculty we got great guest speakers in the finance workshops. Naturally, I had more active dialogue with fellow students, many of whom became excellent talking-partners and friends over the years. Cliff Asness is of course the best known. I humbly thank him for the characteristically witty and insightful foreword and for making it clear to the reader in the first lines of his foreword that I am insane in a good way.

I have been lucky with bosses: my managers at the Bank of Finland taught me the ropes and assigned me the role of a bridge between academia and practitioners much before I had any expertise to fulfill this role. After my Chicago years, my bosses at Salomon Brothers’ storied Bond Portfolio Analysis Group let me balance research and market roles, always stressing the value of conveying complex ideas as intuitively as possible. At Brevan Howard, the co-CEOs allowed me to take different roles, some outside the core hedge fund business, and recognized the value of this book for institutional investors. It helps that the book’s themes have little to do with Brevan Howard’s core approach of tactical rates trading based on fundamental macro-views with a focus on trade construction and risk management, so I will not be revealing any proprietary trade secrets.

This book has been hugely influenced by my regular meetings in Oslo discussing the long-run investment strategy for Norway’s sovereign wealth fund. One outgrowth of those meetings has been even more inspirational—our trialogue with Knut Kjaer and Andrew Ang about diverse long-horizon investor topics.

I have benefited from the thinking of fellow students, colleagues, customers, and research peers in academia and business. Some of the best sources I have yet to meet personally, but I am a voracious reader—to which this book’s lengthy reference list attests. There are too many people to thank by name, but I make an exception for Rory Byrne to whom this book is dedicated. For several years Rory was my main partner in developing and implementing systematic trading models and always a sensible sounding board. Sadly, Rory succumbed last year to a persistent tumor at the age of 35.

A most emphatic thank-you goes to Laurence Siegel, Knut Kjaer, Matti Ilmanen, and Victor Haghani who carefully read the manuscript (or evolving versions of it) and greatly improved the book. I am also grateful to Andrew Ang, Cliff Asness, William Bernstein, Francis Breedon, Alistair Byrne, Adrian Eterovic, Kenneth French, Pal Haugerud, Susan Hudson-Wilson, Doug Huggins, Ray Iwanowski, Matthew James, Robert Kosowski, John Liew, Thomas Maloney, Mikko Niskanen, Lasse Heje Pedersen, Jonas Rinné, Rudi Schadt, Matti Suominen, Etienne Varloot, and Gerlof de Vrij, for their helpful comments on parts of my manuscript. I also thank my editors Pete Baker, Aimee Dibbens, Vivienne Wickham and their colleagues at Wiley for all their help, as well as Neil Shuttlewood, whose company OPS Ltd managed the project. Of course, the responsibility for any errors is mine. In a work of this size, some errors are bound to creep in. I welcome any comments on them as well as other feedback (antti.ilmanen@gmail.com). I credit my data sources separately in Appendix B.

Finally, I thank my family, the source of the most precious expected and realized returns. The family in Finland: My mother and siblings as well as my late father who taught me the love of reading through example and who urged me to read in a way that advances my knowledge systematically (“try to position each new piece of knowledge in its correct place in the star sky”). My Nordic background and values likely helped counterbalance any free market ideology picked up at UofC or material interests in a banking and hedge fund career. And the family in Bad Homburg: My rocks, dear Annette as well as Kukka and Akseli, I am hugely grateful for your understanding during this long project. I just hope I can be as supportive when it is your turn.

Bad Homburg, November 2010

Abbreviations and acronyms

AM Arithmetic Mean

ATM At The Money (option)

AUM Assets Under Management

BEI Break-Even Inflation

BF Behavioral Finance

B/P

BRP

Book/Price, book-to-market ratio

Bond Risk Premium, term premium

B-S Black–Scholes

C-P BRP

Cochrane–Piazzesi Bond Risk Premium

CAPM Capital Asset Pricing Model

CAY Consumption wealth ratio

CB Central Bank

CCW

CDO

Covered Call Writing

Collateralized Debt Obligation

CDS Credit Default Swap

CF Cash Flow

CFNAI

Chicago Fed National Activity Index

CFO Chief Financial Officer

CMD Commodity (futures)

CPIyoy Consumer Price Inflation year on year

CRB Commodity Research Bureau

CRP

Credit Risk Premium (over Treasury bond)

CRRA Constant Relative Risk Aversion

CTA Commodity Trading Advisor

DDM Dividend Discount Model

DJ CS Dow Jones Credit Suisse

DMS Dimson–Marsh–Staunton

D/P

Dividend/Price (ratio), dividend yield

DR Diversification Return

E( )

EMH

E/P

Expected (conditional expectation)

Efficient Markets Hypothesis

Earnings/Price ratio, earnings yield

EPS Earnings Per Share

ERP

Risk Premium

LSV

Lakonishok–Shleifer–Vishny

LtA Limits to Arbitrage

LTCM Long-Term Capital Management

MA Moving Average

MBS (fixed rate, residential) Mortgage-Backed Securities

MIT-CRE

MIT Center for Real Estate

MOM Equity MOMentum proxy

MSCI

Morgan Stanley Capital International

MU Marginal Utility

NBER National Bureau of Economic Research

NCREIF National Council of Real Estate Investment Fiduciaries

OAS

Option-Adjusted (credit) Spread

OTM Out of The Money (option)

P Price

P/B

P/E

Price/Book (valuation ratio)

Price/Earnings (valuation ratio)

PE Private Equity

PEH

Pure Expectations Hypothesis

PT Prospect Theory

r Excess return

R Real (rate)

RE Real Estate

REITs

Real Estate Investment Trusts

RWH Random Walk Hypothesis

S Spot price, spot rate

SBRP

Survey-based Bond Risk Premium

SDF Stochastic Discount Factor

SMB Small Minus Big, size premium proxy

SR Sharpe Ratio

SWF Sovereign Wealth Fund

TED Treasury–Eurodollar (deposit) rate spread in money markets

TIPS Treasury Inflation-Protected Securities, real bonds

UIP Uncovered Interest Parity (hypothesis)

VaR Value at Risk

VC Venture Capital

VIX A popular measure of the implied volatility of S&P 500 index options

VMG Value Minus Growth, equity value premium proxy

WDRA Wealth-Dependent Risk Aversion

X Cash flow

Y Yield

YC

YTM

YTW

Yield Curve (steepness), term spread

Yield To Maturity

Yield To Worst

Antti Ilmanen is a Senior Portfolio Manager at Brevan Howard, one of Europe’s largest hedge fund managers.

The views expressed in this book are the author’s own views and are not the views of any of the Brevan Howard group of affiliated companies.

The information and opinions contained in this document are for information and discussion purposes only, do not constitute a financial promotion and do not purport to be full or complete. Whilst the author has used his best efforts to ensure the accuracy or completeness of any information contained herein, no reliance may be placed for any purpose on the information or opinions contained in this book or their accuracy or completeness. No representation, warranty or undertaking, express or implied, is given as to the accuracy or completeness of the information or opinions contained in this book and no liability is accepted for the accuracy or completeness of any such information or opinions.

This book does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or purchase, any shares or any other interests nor shall it or the fact of its distribution form the basis of, or be relied on in connection with, any contract thereof. This book is not intended to constitute, and should not be construed as, investment advice.

Part I

Overview, historical returns, and academic theories

1. Introduction

2. Whetting the appetite: Historical averages and forward-looking returns

3. The historical record: The past 20 years in a longer perspective

4. Road map to terminology

5. Rational theories on expected return determination

6. Behavioral finance

7. Alternative interpretations for return predictability

Introduction

• This book covers the general topic of expected returns on investments. The traditional paradigm among institutional investors focuses too much on historical performance and too narrowly on asset class allocation. This book argues that investment decision making should be broadened beyond the asset class perspective and a wider set of inputs should be used for assessing expected returns.

• The book considers in detail a wide range of return sources: major asset classes (stocks, bonds, and alternative investments) and strategy styles (value, carry, momentum, and so forth) as well as risk factors (such as growth, inflation, and liquidity).

Another random document with no related content on Scribd:

kyphosis of, 444 lordosis of, 461 operations on, 636

Pott’s disease of, 444 causes of, 445 complications of, 446 diagnosis of, 448 prognosis of, 448 sequelæ of, 446 symptoms of, 445 treatment of, 448 by apparatus, 448 by forcible contraction, 450 spondylitis of, 444 traumatic, 462 spondylolisthesis, 462 diagnosis of, 463 symptoms of, 462 treatment of, 463 tuberculosis of, 424 typhoid, 462 wounds of, gunshot, 624 penetrating, 624

Spirochæta pallida, 123

Splay-foot, 468

Spleen, abscess of, 941 anomalies of, 940 carcinoma of, 943 cysts of, 943 displacements of, 942 gangrene of, 941 hypertrophies of, 941 injuries of, 941 neoplasms of, 943 operations on, 943 splenectomy, 943 splenopexy, 942

splenotomy, 943

sarcoma of, 943

syphilis of, 138 wounds of, 233

Splenectomy, 943

Splenic anemia, 31 fever, 106. See Anthrax.

Splenitis, suppurative, 941

Splenomedullary leukemia, 32

Splenomegaly, 942

Splenopexy, 942

Splenotomy, 943

Spondylitis, 444 suppurative, of abdominal wall, 783 traumatic, 462

Spondylolisthesis, 462 diagnosis of, 463 symptoms of, 462 treatment of, 463

Sponges, sterilization of, 247

Sprains of joints, 380 symptoms of, 380 treatment of, 380 of muscles, 329 of spinal column, 628 treatment of, 629

Sprengel’s deformity, 458

Staffordshire knot, 241

Staphylococcus pyogenes albus, 52 aureus, 52 epidermidis, 52

Staphyloma, 598

Staphylorrhaphy, 654

Status lymphaticus, 163 diagnosis of, 164 treatment of, 165 thymicus, 163

Steatomas, 310

Stenosis, pyloric, operations for, 808

Stenson’s duct, cysts of, 641

Stercoremia, 83

Sterilization by boiling water, 244 of dressings, 247 by formalin, 244 fractional, 244 of hands, 245 by heat, 243 of instruments, 246 by mustard flour, 245 of sponges, 247 of suture materials, 247

Sternum, dislocations of, 528 fractures of, 491 symptoms of, 492 treatment of, 492 malformations of, 718

Stillicidium, 982

Stokes’ method of amputation of thigh, 1043

Stomach, anastomosis of, 816 cancer of, 801 symptoms of, 802 treatment of, 803 dilatation of, acute, 795 symptoms of, 796 treatment of, 796 chronic, 796 operations for, 811 fistulas of, 801 foreign bodies in, 794 operations for, 806 symptoms of, 794 treatment of, 794 hour-glass, 793 injuries of, 793

leather-bottle, 793

malformations of, acquired, 793

congenital, 793

nerves of, 793

operations on, 805

gastrectomy, 813

gastro-enterostomy, 811, 817

gastrojejunostomy, 816

gastrorrhaphy, 806

gastrostomy, 806

gastrotomy, 806

pylorectomy, 813

pylorus of, stenosis of, 799 symptoms of, 799 treatment of, 799 rupture of, 794 syphilis of, 795 tetany of, 798 tuberculosis of, 795 tumors of, 801 ulcer of, 799

symptoms of, 800 treatment of, 800

wall of, inflammation of, 804 wounds of, 794

penetrating, operations for, 805

Stomatitis, 657

gangrenous, 75, 658

ulcerative, 657

Stovaine, 207

Strains of muscles, 329

Strangulated hernia, diagnosis of, from appendicitis, 858

intestinal obstruction from, 829

Strawberry growths, 367

Streptococcus erysipelatis, 52 pyogenes, 53

Streptothrix maduræ, 100

Stretching of nerves, 612

Stricture of biliary ducts, 921 of esophagus, 742 of intestines, large, 870 obstruction from, 832 symptoms of, 828 treatment of, 828 small, 827 of larynx, 684 symptoms of, 684 treatment of, 684 of rectum, 877 treatment of, 877 of ureter, 973 of urethra, 1011

Struma, 283, 712 fibrosa, 284 parenchymatosa nodosa, 284

Strumitis, 717

Stye, 600

Stypticin, 235

Styptics for control of hemorrhage, 235

Subclavian artery, aneurysm of, 345 ligation of, 354

Subclavicular dislocations, 531

Subcoracoid dislocations, 531

Subcutaneous tubercle, painful, of skin, 313

Subdiaphragmatic abscess, 753 treatment of, 754

Subdural hemorrhages, 564

Subglenoid dislocations, 531

Subhyoid pharyngotomy, 664

Subluxation, 524 See Dislocations

Submaxillary angina, infectious, 703

Subphrenic abscess, 753 treatment of, 754

Subspinous dislocations, 532

Subungual exostoses, 272

Sunburn, 303

Suppression of urine, 982

Suppuration, 57

Supracondyloid amputations, 1043 fracture of humerus, 497

Supra-orbital nerve operations on, 613

Suprapubic prostatectomy, 998

Suprarenal epithelioma, 292

Surgical diseases, 79 common to man and animals, 97 fever, 85 cause of, 85 diagnosis of, from poisoning by drugs, 85 erysipelas, 93 pyemia, 90 sapremia, 86 chronic, 87 septicemia, 87 cryptogenetic, 87 spontaneous, 87 methods, 177 principles, 177 sequelæ of disease, 166 cholera, 166 dental caries, 169 diphtheria, 168 dysentery, 166 endocarditis, 169 gonorrhea, 169 influenza, 167 measles, 167 mumps, 168 pneumonia, 167 puerperal state, 169 scarlatina, 167 syphilis, 169

typhoid fever, 167 variola, 169

Sutures, 240

Billroth’s chain-stitch, 241 of bloodvessels, 349 end-to-end, 350 lateral, 349 continuous, 241 of heart wounds, 335 (note) interrupted, 241 of intestines, 840 modified plate, 241 quill, 241 of nerves, 612 removal of, 242 of tendons, 324 transfixion, 241

Swelling, acute, 22 chronic, 22

Sylvester’s method of artificial respiration, 204 Symblepharon, 603

Sympathectomy, 714

Sympathetic ophthalmitis, 595 treatment of, 596

Syncheilia, 639

Syncytioma, 292

Synovial cysts, 262

Synovitis, 382 acute, 383 treatment of, 383 chronic, 386 treatment of, 386 dry, 383 gonorrheal, 385 of jaws, acute, 667 purulent, 383 symptoms of, 383

treatment of, 385 treatment of, 385

Syphilides, 130 pustular, 132

ecthyma, 132 rupia, 132 pustulocrustaceous, 132 squamous, 131

Syphilis, 122 of abdominal wall, 783 of axilla, 751 of bones, 135, 426 of brain, 138 of breast, 759 of bursæ, 136 of cervical lymph nodes, 705 chancre, 126 bubo, 128

diagnosis of, from epithelioma, 127 dry papule, 126 extragenital, 127

Hunterian, 127 lymphatic involvement in, 128 mixed, 127 pathology of, 128 superficial erosion, 127 treatment of, 128 in children, 139

Colles’ law, 139

Profeta’s law, 139 of colon, 869 constitutional, 129, 132 of cornea, 137 of corpora cavernosa, 138 of ear, 137 eruptions of, 130 papular, 131

lenticulo, 131 miliary, 131 pustular, 132 pustulocrustaceous, 132 evolution of, 123 of eye, 136, 597 of face, 640 of genitalia, 138 gumma of, 133 Hutchinson’s teeth in, 140 induration of, 126 initial lesion in, 126 of intestines, 827 of joints, 135 of kidneys, 138, 964 of larynx, 138, 686 treatment of, 686 lesions of, 124 of liver, 138, 914 of lymph nodes, 376 manner of contagion of, 123 of mesentery, 939 of mouth, 657 of mucous membranes, 132 of muscles, 136, 331 of nervous system, 138 of orbit, 597 of oropharynx, 137 primary lesion, location of, 125 of rectum, 138, 876 secondary infection in, 169 lesion, 129 secretions of, 124 of skin, 130, 308 of spermatic cord, 1019 of spinal cord, 138 of spleen, 138

of stomach, 795 teeth in, 140 of tendons, 136 tertiary, 132 of skin, 133 of testicle, 138, 1016 of tongue, 659 of tonsils, 662 treatment of, 140 ulcer of, symptoms of, 125 of uvula, 683 of vascular system, 135 virus of, 123

Syphilitic arthritis, 385 bubo, 128 gumma of lung, 732

Syphilodermas, 130

Syringomyelia, 621

Syringomyelocele, 263, 626

TT mesenterica, 939

Tænia solium, 310

Tagliacozzi’s method of rhinoplasty, 644

Talipes, 465 calcaneus, 471

equinovarus, 466 treatment of, 466 equinus, 470 causes of, 470 treatment of, 471 valgus, 468 etiology of, 468 treatment of, 469

Talma’s operation on omentum, 936

Tapping, paracentesis by, 185

Tarantula, poisoning by, 172

Tarsectomy, 467

Tartar on teeth, 657

Tattoo marks, 318, 720

Taxis, 899

T-bandage, 191

Teale’s method of amputation of foot, 1042

Teeth, caries of, 657, 664 treatment of, 665 cysts of, 666 eruption of, faulty, 665 extraction of, 666 accidents from, 666 instruments required, 666 malformations of, 652 odontoma of, 665 re-implantation of, 667 tartar of, 657 tumors of, 665

Telangiectasis, 277

Temporal artery, ligation of, 352

Temporomaxillary joint, ankylosis of, 667 dislocation of, 667 postgonorrheal arthritis of, 667 resection of, 668 synovitis of, acute, 667

Temporosphenoidal abscess, 569

Tendon sheaths, tuberculosis of, 118

Tendons, dislocation of, 330 grafting of, 324 injuries of, 218 ligation of, 326 surgical diseases of, 321 suture of, 324 syphilis of, 136 transplantation of, 324

Tendoplasty, 322

Tendosynovitis, 321 chronic, 322

treatment of, 322

suppurative, 321

treatment of, 321

Tendovaginitis, gonococcus of, 331

Tenorrhaphy, 324

Tenotomy, 327

Teratomas, 268

embryonal adenosarcoma, 268 of thyroid, 712

Tertiary syphilis, 132

Testicle, absence of, 1015

atrophy of, 1015 cancer of, 1017

chondroma of, 1017

congenital abnormalities of, 1014 contusions of, 1015

cystic degeneration of, 260 cysts of, 1016

epididymitis, 1016

treatment of, 1017

fibroma of, 1017

gonorrhea of, 151 hematoma of, 1015

hydrocele of, encysted, 260 injuries to, 1015 lipoma of, 1017 orchitis, 1017

treatment of, 1017

retained, 1014

treatment of, 1014

syphilis of, 138, 1016

tuberculosis of, 118, 1015

treatment of, 1016 tumors of, 1017

Tetanin, 98

Tetanotoxin, 98

Tetanus, 97 cephalicus, 99 chronic, 100 death in, 100 diagnosis of, 101 from hysteria, 101 etiology of, 97 hydrophobicus, 99 of newborn, 97, 99 parasitic nature of, 98

postmortem appearances in, 100 prognosis of, 100 toy-pistol, 97 treatment of, 101

Tetany, bacillus of, 54 gastric, 798

Thecitis, 328

Thiersch method of skin grafting, 188

Thigh, amputation of, 1043 above knee, 1044 fracture of, 509 diagnosis of, 511 prognosis of, 511 treatment of, 512

Thoracentesis, 736, 746

Thoracic duct, injuries to, 725 treatment of, 726

viscera, injuries to, 724 walls, diseases of, 726

Thoracoplastic operations, 748

Thoracotomy, 747 drainage in, 747 irrigation in, 747

Thorax, actinomycosis of, 729 carcinoma of, 730

chondroma of, 730

fibroma of, 729 granuloma of, 729 injuries to, 721 lipoma of, 729 malformations of, 718, 719 operations on, 746 osteoma of, 730 sarcoma of, 730 tumors of, 729 treatment of, 730 wounds of, gunshot, 230

Thrombo-arteritis, 91

Thrombophlebitis, 37, 90

Thrombosis, 34 annular, 35 causes of, 35 following abdominal operations, 784 gangrene from, 73 infective, 36, 570 marasmic, 36, 570 mechanical, 36 of mesenteric vessels, 938 obstructive, 36 parietal, 35 primary, 35 propagated, 36 sinus, 570 diagnosis of, 571 prognosis of, 571 symptoms of, 570 treatment of, 573 traumatic, 36 valvular, 35

Thrombus, calcification of, 36 decolorization of, 36 organization of, 36

softening of, 37

Thrush, oïdium albicans of, 657

Thumb, amputation of, 1029

Thymic asthma, 163

Thymus, hypertrophy of, 717, 751 inflammation of, 717

Thyroglossal duct, 710

Thyrohyoid cysts of neck, 707

Thyroid arteries, inferior, ligation of, 353 body, adenoma of, 712

bronchocele, 712

congenital affections of, 710

endothelioma of, 712

goitre of, 712

hypertrophy of, acute idiopathic, 711

intra-uterine, 711

sarcoma of, 712

struma of, 712

teratomas of, 712 tumors of, 711

dermoids, 267

Thyroidectomy, 715

Thyroidism, 82

Thyroiditis, 711

Thyroids, accessory, 710

Thyrotomy, 674, 688

Tibia, dislocations of, 543 fractures of, 518 treatment of, 521

Tibial arteries, ligation of, 360 nerve, operations on, 623

Tibiotarsal amputations, 1037

Tic douloureux, 640

Toe-nail, ingrowing, 318

Toes, amputation of, 1034 hammer, 321

treatment of, 321

Tongue, absence of, 652

actinomycosis of, 659

bifid, 652

cysts of, retention, 659

epithelioma of, 660

treatment of, 660

gangrene of, 659

inflammation of, 658

leukoplakia of, 659

treatment of, 659

macroglossia of, 660 malformations of, 652

nevi of, 659

operations on, 661

Kocher’s, 661

Langenbeck’s, 662

Regnoli-Billroth’s, 661

Sédillot’s, 662

Whitehead’s, 661

papilloma of, 659

ranula of, 660

syphilis of, 659 -tie, 652

tuberculosis of, 659 tumors of, 659

Tonometer, use of, 177

Tonsillotomy, 663

Tonsils, absence of, 662

calculi of, 663

enlarged, 662

foreign bodies in, 663

hypertrophy, 662

infection through, 49

syphilis of, 662

tuberculosis of, 662 tumors of, 664

Torsion, control of hemorrhage by, 236

of omentum, 935

Torticollis, 457 diagnosis of, 458 pathology of, 457 treatment of, 458

Tourniquet for control of hemorrhage, 234

Toxic antiseptics, 175

Toy-pistol tetanus, 97

Trachea, operations on, 691 rupture of, 699 scabbard, 713 tumors of, 687 wounds of, 699

Tracheal tugging, 345

Tracheocele, 707

Tracheotomy, 691

Trachoma, 599

Transfixion suture, 241

Transfusion of blood, 185

Transhyoid pharyngotomy, 664

Transplantation of bone, 431 of tendons, 324

Transudates, 23

Trauma as cause of tumor, 255

Traumapnea, 724

Traumatic abscess of brain, 567 erysipelas, 93, 94 fever, 85. See Surgical fever. hematoma of scalp, 218 hernia, 890 insanity, surgical treatment of, 582 intraventricular hemorrhage, 564 mania, 175 neuroma, 280 othematoma, 605 peritonitis, 786 spondylitis, 462

thrombosis, 36 Treatment of abscess, 60 of bone, 426 of brain, 573 of liver, 912 of rectum, 879 of actinomycosis, 110 of acute catarrh of biliary passages, 918 cholecystitis, 921 pancreatitis, 948 after abdominal operations, 777 of adenoids of pharynx, 680 of aneurysm of abdominal aorta, 346 of angioma of veins, 367 of ankylosis, 405 of anthrax, 107 of arthritis, chronic, 386 deformans, 389 tuberculous, 398 of atrophy of muscles, 332 of biliary calculi, 926 of boils, 304 of bow-leg, 465 of bunions, 311 of burns, 301 x-ray, 304 of carbuncle, 305 of carcinoma, 295 of breast, 763 of intestines, 828 of rectum, 887 of stomach, 803 of cardiospasm, 798 of caries of hip, 454 of cerebral palsies, 478 of cervical lymph-node affections, 706 of chancre, 128

of chancroid, 145 of cholelithiasis, 926 of chondroma, 272 of chronic affections of pancreas, 951 pancreatitis, 950 prostatitis, 995 sapremia, 87 tendosynovitis, 322 of cold abscess, 114 peri-articular, 399 of compression of brain, 562 of concussion of brain, 559 of chest, 722 of spine, 629 of congenital anomalies of neck, 698 club-foot, 466 dislocation of hip, 474 of congestion, 23 of contraction of fasciæ, 320 of muscles, 332 of contusions, 212 of brain, 560 of chest, 722 of cryptorchidism, 1014 of curvature of spine, 460 of cutaneous horns, 311 of cystitis, 985 of cysts of pancreas, 952 of skin, 310 of dacryocystitis, 600 of delirium tremens, 174 of dental caries, 665 of dermatitis calorica, 299 of desmoids, 271 of dilatation of stomach, 796 of dislocations, 527 of clavicle, 529

of elbow, 536 of foot, 544 of hip, 539 of jaw, 528 of knee, 544 metacarpophalangeal, 537 of patella, 543 of shoulder, 532 of spine, 632 of duodenal ulcers, 826 of Dupuytren’s contraction, 320 of ectopia of bladder, 978 of epididymitis, 1017 of epistaxis, 681 of epithelioma of skin, 315 of tongue, 660 of erysipelas, 95 of exophthalmic goitre, 714 of exophthalmos, 594 of exstrophy of bladder, 978 of fat embolism, 40 of fibroma molluscum, 313 of fistula, 63 of rectum, 880 of floating liver, 911 of foreign bodies in esophagus, 740 in pharynx, 673 in stomach, 794 of fractures, 486 of clavicle, 493 Colles’, 504 of femur, 513 of fibula, 521 of forearm, 501 of humerus, 495 of inferior maxilla, 490 of leg, 521

Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.